Kelly Financial Services’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-46
| Closed | -$1.7K | – | 226 |
|
|
2024
Q2 | $1.7K | Hold |
46
| – | – | ﹤0.01% | 604 |
|
|
2024
Q1 | $1.93K | Hold |
46
| – | – | ﹤0.01% | 598 |
|
|
2023
Q4 | $1.82K | Hold |
46
| – | – | ﹤0.01% | 590 |
|
|
2023
Q3 | $1.27K | Hold |
46
| – | – | ﹤0.01% | 596 |
|
|
2023
Q2 | $1.56K | Hold |
46
| – | – | ﹤0.01% | 568 |
|
|
2023
Q1 | $1.66K | Hold |
46
| – | – | ﹤0.01% | 540 |
|
|
2022
Q4 | $2.05K | Hold |
46
| – | – | ﹤0.01% | 505 |
|
|
2022
Q3 | $1.29K | Hold |
46
| – | – | ﹤0.01% | 549 |
|
|
2022
Q2 | $1.24K | Hold |
46
| – | – | ﹤0.01% | 538 |
|
|
2022
Q1 | $1.57K | Hold |
46
| – | – | ﹤0.01% | 544 |
|
|
2021
Q4 | $1.78K | Hold |
46
| – | – | ﹤0.01% | 552 |
|
|
2021
Q3 | $2.48K | Sell |
46
-1,492
| -97% | -$80.6K | ﹤0.01% | 494 |
|
|
2021
Q2 | $46K | Buy |
1,538
+1,492
| +3,243% | +$44.6K | ﹤0.01% | 467 |
|
|
2021
Q1 | $948 | Hold |
46
| – | – | ﹤0.01% | 553 |
|
|
2020
Q4 | $806 | Hold |
46
| – | – | ﹤0.01% | 527 |
|
|
2020
Q3 | $682 | Hold |
46
| – | – | ﹤0.01% | 510 |
|
|
2020
Q2 | $598 | Hold |
46
| – | – | ﹤0.01% | 526 |
|
|
2020
Q1 | $76 | Hold |
46
| – | – | ﹤0.01% | 560 |
|
|
2019
Q4 | $103 | Hold |
46
| – | – | ﹤0.01% | 545 |
|
|
2019
Q3 | $98 | Hold |
46
| – | – | ﹤0.01% | 537 |
|
|
2019
Q2 | $123 | Hold |
46
| – | – | ﹤0.01% | 486 |
|
|
2019
Q1 | $226 | Buy |
+46
| New | +$226 | ﹤0.01% | 464 |
|